Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on June 5, 2026

Jun. 5, 2026

A New Award from MSCRF to Lentigen Technology, Inc. to Commercialize Curative Approaches for Sickle Cell Disease

Indeterminate EIN Presswire

Jun. 5, 2026

Beljanski Foundation Shares Emerging Research Ahead of National Cancer Survivors Day That Hopes To Prevent Recurrence

Indeterminate EIN Presswire

Jun. 5, 2026

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems

Indeterminate GlobeNewswire

Jun. 5, 2026

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Indeterminate GlobeNewswire

Jun. 5, 2026

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

Indeterminate GlobeNewswire

Jun. 5, 2026

Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor…

Indeterminate GlobeNewswire

Jun. 5, 2026

Vireo Growth Inc. Completes Acquisition of Bridgewell Agribusiness LLC and Plans to Acquire Dispensaries in Nevada and Maryland

Indeterminate GlobeNewswire

Jun. 5, 2026

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Premier Health of America Announces Grant of Management Cease Trade Order

Indeterminate GlobeNewswire

Jun. 5, 2026

New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity

Indeterminate GlobeNewswire

Jun. 5, 2026

DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 5, 2026

DBV Technologies participera à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs

Indeterminate GlobeNewswire

Jun. 5, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Banner Health appoints Dr. John Rares Almasan as senior vice president, chief AI, data and infrastructure officer

Indeterminate GlobeNewswire

Jun. 5, 2026

Voting Rights and Shares Capital of the Company

Indeterminate GlobeNewswire

Jun. 5, 2026

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Indeterminate GlobeNewswire

Jun. 5, 2026

Memocept Under Investigation: Shocking Memocept Brain Support Customer Complaints, Ingredient Claims, Effectiveness Questions, and Serious Side Effect Risks Examined

Indeterminate GlobeNewswire

Jun. 5, 2026

HRC Technology Solutions LLC Expands Scope and Is Successfully Reappraised at CMMI® Services Maturity Level 3, Reinforcing Its AI-Driven Operating Model

Indeterminate GlobeNewswire

Jun. 5, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8

Indeterminate GlobeNewswire